Sankala Group »

Vertex Pharmaceuticals Incorporated shares owned by Sankala Group

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Sankala Group from 13F filings

Historical chart of Sankala Group investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Sankala Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Sankala Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $116k 233 496.83

More positions owned by Sankala Group

Ishares Treasury Floatngrate Bd Etf Etf (TFLO)
Spdr Gold Minishares Etv Etf (GLDM)
Ishares Select Dividend Etf Etf (DVY)
Schwab Short Term Us Treasury Etf Etf (SCHO)
St Stret Spdr S&p 600 S C Vl Etf Iv Etf (SLYV)
Vanguard Extended Duration Treasury Index Fund Etf Shares Etf (EDV)
Vanguard S&p 500 Etf Etf (VOO)
Ishs 25 Yr Treasury Strips Bnd Etf Etf (GOVZ)
Ishares Core Msci Emerging Etf Etf (IEMG)
Microsoft Corp Equity (MSFT)
Alpha Architect Tail Risk Etf Etf (CAOS)
Ishares Core S&p 500 Etf Etf (IVV)
Emqq The Emerging Mkt Intr Etf Etf (EMQQ)
Wisdomtree Japan Smalcp Dividend Etf Etf (DFJ)
Ishares Gold Tr Micro Undiv Benf Etv Etf (IAUM)

View all positions for Sankala Group

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated